Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris
Update: 2024-12-12
Description
"It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they are not destroyed during nebulization." - Dr. Carsten Rudolph, CEO and Managing Director at Ethris
Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Dr. Carsten Rudolph, as they discuss the current state and bright future of nasal vaccine technology.
Tune in today!
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
